663 1/,55)1

Aor

JIM- (td{
GOVERNMENT OF INDIA
 0
nivaHealth Insurance

DATE 2.0S- 2023

Name: Morio,

DOB:- OS Ok-k, 1'1 5

Disease /treatment
if any: Pio b'Ickhe:[ s illo-1-cotxvirrN soo mak lac 1- man4)),

1
Weight Height Blood Pressure

0
Smoking: Alcohol tc)

1G/NON-FASTING PcksA-

Phlebotomist: alcklork

SAMPLE DROP AT
epLUs
c
e
men
Self Test done by client:
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer

CBC 1
HAEMOGLOBIN (Hb) 11.3 gm/dl 11.5 - 16.5
TOTAL LEUCOCYTE COUNT (TLC) 5,160 /cumm 4000 - 11000
Adult 4000 - 11000 /cumm
Child 6000 - 13500 /cumm
Infants 6000 - 18000 /cumm
New Born 10000 - 25000 /cumm

DIFFERENTIAL LEUCOCYTE COUNT (DLC)

NEUTROPHIL 58 % 40 - 75
LYMPHOCYTE 34 % 20 - 45
EOSINOPHIL 03 % 01 - 06
MONOCYTE 05 % 02 - 10
BASOPHIL 0 % 0-0
ERYTHROCYTE SED.RATE (WIN) 13 mm/1st hr. 0 - 20
R B C COUNT 3.76 Millions/cmm 3.8 - 4.8
P.C.V / HAEMATOCRIT 33.9 % 35 - 45
MCV 90.16 fl. 80 - 100
MCH 29.03 Picogram 27.0 - 31.0
MCHC 32.34 gm/dl 30.0 - 36.0
PLATELET COUNT 1.76 Lakh/cmm 1.50 - 4.00

DR. SARWAT FATMA

M.B.B.S M.D. (PATHOLOGY) DMC REGN :59363
CONSULTANT PATHOLOGIST

Page 1
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

BIOCHEMISTRY
BLOOD SUGAR FASTING 116.9 mg/dl 60 - 110

*****

DR. SARWAT FATMA

M.B.B.S M.D. (PATHOLOGY) DMC REGN :59363
CONSULTANT PATHOLOGIST

Page 2
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

HAEMATOLOGY

HB A1C 6.7 % 4.5 - 6.4

INTERPRETATION :-
Normal - 4.2 - 6.4 %
Good diabetic control - 6.4 - 6.8 %
Fair control - 6.8 - 8.2 %
Poor control - > 8.2 %

REMARKS:-

The glycosylated hemoglobin assay has been validated as a reliable indicator of mean blood
glucose levels for a period of 8-12 week period prior to HBA1C determination.
ADA recommends the testing twice a year in patients with stable blood glucose, and
quarterly, if treatment changes, or if blood glucose levels are unstable.

LIPID PROFILE
TRIGLYCERIDES 101.4 mg/dL 60 - 165

Page 3
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

TOTAL CHOLESTEROL 168.3 mg/dL 125 - 200

H D L CHOLESTEROL DIRECT 57.9 mg/dL 30 - 70
VLDL 20.28 mg/dL 10 - 35
L D L CHOLESTEROL DIRECT 90.12 mg/dL 63.0 - 150.0
TOTAL CHOLESTEROL/HDL RATIO 2.907 0.0 - 5.8
LDL / HDL CHOLESTEROL RATIO 1.556 0.00 - 3.55
KIDNEY FUNCTION TEST (KFT)
BLOOD UREA 26.3 mg /dl 15.0 - 45.0
SERUM CREATININE 0.75 mg%/dl 0.4 - 1.4
SERUM URIC ACID 3.54 mg%/dl 2.4 - 5.7
CALCIUM 8.71 mg/dl 8.0 - 10.5
INORGANIC PHOSPHORUS 3.65 mg/dl 2.5 - 5.0
SODIUM 140.4 mmol/L 136.0 - 149.0
POTASSIUM 4.26 mmol/L 3.5 - 5.5
CHLORIDE 105.6 mmol/L 98.0 - 109.0
LIVER FUNCTION TEST (LFT)
BILIRUBIN TOTAL 0.78 mg/dl 0.1 - 1.2
CONJUGATED (D. Bilirubin) 0.19 mg/dl 0 - 0.3
UNCONJUGATED (I.D.Bilirubin) 0.59 mg/dl 0 - 0.9
SGOT 23.5 IU/L 0 - 40
SGPT 27.6 IU/L 0.0 - 40.0
ALKALINE PHOSPHATASE 58.92 U/L 35.0 - 104.0

Page 4
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

TOTAL PROTEIN 7.12 gm/dl 6.0 - 8.3

ALBUMIN 3.91 gm/dl 3.2 - 5.0
GLOBULIN 3.21 gm/dl 2.3 - 3.5
A/G RATIO 1.218 0 - 3.5
GAMMA GT 31.5 IU/L 6.0 - 42.0

*****

DR. SARWAT FATMA

M.B.B.S M.D. (PATHOLOGY) DMC REGN :59363
CONSULTANT PATHOLOGIST

Page 5
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

IMMUNOLOGY
T3 154.6 ng/dl 70 - 204
T4 7.98 ug/dl 5.0 - 12.5
Chemiluminescence

TSH 2.31 uIU/ml

Chemiluminescence
REFERENCE RANGE

PAEDIATRIC AGE GROUP

0-3 DAYS 1-20 ulu/ ml
3-30 DAYS 0.5 - 6.5 ulu/ml
I MONTH -5 MONTHS 0.5 - 6.0 ulu/ml
6 MONTHS- 18 YEARS 0.5 - 4.5 ulu/ml

ADULTS 0.45 - 4.50 uIu/ml

Note: TSH levels are subject to circadian variation, rising several hours
before the onset of sleep, reaching peak levels between 11 pm to 6 am.
Nadir concentrations are observed during the afternoon.
Diurnal variation in TSH level approximates + 50 %, hence time of the day
has influence on the measured serum TSH concentration.

Page 6
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

URINE EXAMINATION TEST

PHYSICAL EXAMINATION
QUANTITY 15 ml.
COLOUR YELLOW
TRANSPARENCY CLEAR
SPECIFIC GRAVITY 1.015
PH 7.5
CHEMICAL EXAMINATION
ALBUMIN NIL
REDUCING SUGAR NIL

MICROSCOPIC EXAMINATION
PUS CELLS 1-2 /HPF
RBC'S NIL /HPF
CASTS NIL
CRYSTALS NIL
EPITHELIAL CELLS 2-3 /HPF
BACTERIA NIL
OTHERS NIL

Page 7
 Patient ID 6531 Date 02/05/2023
Name Mrs. NONIKA KAPOOR Ref. TPA H.A
Age and Sex 58 Yrs./ Female Ref. Insurer
Test Name Obtained Value Unit Normal Value

SEROLOGY
VITAMIN D 25 HYDROXY
CLIA

Vitamin D, 25 - Hydroxy 20.3 ng/ml ( > 30 ng/ml)

Expected Value:
A more recent consensus of expert leads to the conclusion that for general health a desirable
concentration
of vitamin D (25-OH) is > 30 ng/ml ( > 75 nmoI/L).

Ref:
Vieth R, et al. The urgent need to recommened an intake of Vitamin D that is effective. Am J Clin Nutr 2007; 85 :649 - 650

Comments

Vitamin D is acquired either by exposure to sunlight or ingestion of food containing food vit D. It is
metabolized to vit D, 25 hydroxy in the liver in the first step by vit D,25-hydroxylase system. A small
amount of it further gets metabolized by hydroxylation in kidney to vit D 1,25 dihydroxy. Since vit D, 25
hydroxy is the predominant circulating form of Vit D in normal population, it is considered to be the most
reliable index of vit D status.
The measurement of 25-OH-D is becoming increasingly important in the management of patients with
various disorders of calcium metabolism associated with Rickets, neonatal hypocalcemia, pregnancy,
nutritional and renal osteodystrophy, hypoparathyroidism, and postmenopausal state.

Increased levels are found in Vit D intoxications.

Decreased levels are detected in Rickets, osteomalacia, secondary hyperparathyroidism, malabsorption of

vit D (e.g. liver diseases, cholestasis), and diseases that increase Vit D metabolism (viz. Tuberculosis,
sarcoidosis, primary hyperparathyroidism).

*****

DR. SARWAT FATMA .

M.B.B.S M.D. (PATHOLOGY) DMC REGN :59363
CONSULTANT PATHOLOGIST

Page 8 of 8
 !
18mm/mv 25mm/sec t g; 32Hz BPL CARDIART 6188T ! 1 10mm/mv 25mm/sec t 3.1v, 32Hr
II
I cy( 1 1<ck
—H

02-0S-2_023
Pat. ID Pat ID

BPL CARDIART 61881 lOmm/mv 25mm/sec t 7.,

" 32Hz BPL CARDIART 6108T
aVR
Z130
aVL
14-75 lotytti aVF

uJNL_ 5-8 F

lOmm/mv 25mm/sec t 1
2 .; 32Hz BPL CARDIART 61138T 18mm/mv 25mm/sec t "4,
11 32Hz
VI V2 1/3

& VMS

CE
Pat.ID
boar
die
•12
•
• Pat ID

7
BPL CARDIART 61881 .44m/mv 251m/sec t g,r ' 32Hz BPL CARDIART 61081
n0
V4 V4sur — V6